ACADIA Pharmaceuticals Inc (ACAD)
16.22
-0.05
(-0.31%)
USD |
NASDAQ |
Nov 21, 14:56
ACADIA Pharmaceuticals Price: 16.22 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 16.25 | 16.38 | 16.05 | 16.27 | 1.084M |
Nov 19, 2024 | 16.81 | 17.03 | 16.04 | 16.21 | 1.562M |
Nov 18, 2024 | 16.81 | 17.17 | 16.59 | 17.03 | 1.835M |
Nov 15, 2024 | 17.14 | 17.30 | 16.37 | 16.77 | 1.827M |
Nov 14, 2024 | 17.68 | 17.77 | 17.00 | 17.02 | 1.374M |
Nov 13, 2024 | 18.13 | 18.15 | 17.58 | 17.59 | 931246.0 |
Nov 12, 2024 | 18.16 | 18.40 | 17.85 | 17.93 | 989746.0 |
Nov 11, 2024 | 17.97 | 18.71 | 17.92 | 18.27 | 1.490M |
Nov 08, 2024 | 17.10 | 17.97 | 17.10 | 17.66 | 1.534M |
Nov 07, 2024 | 15.69 | 17.49 | 15.68 | 17.20 | 3.217M |
Nov 06, 2024 | 15.70 | 15.85 | 15.18 | 15.79 | 2.109M |
Nov 05, 2024 | 14.74 | 15.03 | 14.41 | 15.00 | 1.869M |
Nov 04, 2024 | 14.73 | 15.02 | 14.60 | 14.62 | 2.794M |
Nov 01, 2024 | 14.66 | 14.87 | 14.52 | 14.81 | 1.214M |
Oct 31, 2024 | 14.70 | 14.77 | 14.45 | 14.59 | 1.076M |
Oct 30, 2024 | 14.64 | 15.00 | 14.57 | 14.77 | 847277.0 |
Oct 29, 2024 | 14.68 | 14.91 | 14.60 | 14.74 | 945595.0 |
Oct 28, 2024 | 14.44 | 14.80 | 14.31 | 14.74 | 819649.0 |
Oct 25, 2024 | 14.52 | 14.60 | 14.34 | 14.34 | 583196.0 |
Oct 24, 2024 | 14.29 | 14.50 | 14.26 | 14.48 | 783734.0 |
Oct 23, 2024 | 14.53 | 14.68 | 14.15 | 14.29 | 1.007M |
Oct 22, 2024 | 14.63 | 14.90 | 14.50 | 14.52 | 794276.0 |
Oct 21, 2024 | 15.30 | 15.56 | 14.53 | 14.76 | 1.584M |
Oct 18, 2024 | 15.19 | 15.37 | 15.04 | 15.30 | 2.127M |
Oct 17, 2024 | 15.11 | 15.26 | 14.96 | 15.17 | 1.007M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
13.01
Minimum
Jun 21 2022
57.00
Maximum
Jul 07 2020
27.02
Average
22.42
Median
Nov 13 2023
Price Benchmarks
Bristol-Myers Squibb Co | 58.27 |
NovaBay Pharmaceuticals Inc | 0.70 |
Palatin Technologies Inc | 0.9146 |
iBio Inc | 2.40 |
Theriva Biologics Inc | 1.24 |
Price Related Metrics
PE Ratio | 20.79 |
PS Ratio | 2.897 |
Price to Book Value | 4.676 |
Price to Free Cash Flow | 13.28 |
Earnings Yield | 4.81% |
Market Cap | 2.699B |
Operating PE Ratio | 23.98 |
Normalized PE Ratio | 20.79 |